Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 HKD | +4.48% | +4.48% | -64.65% |
Sales 2023 | 103M 14.21M 111M | Sales 2024 * | 130M 17.95M 140M | Capitalization | 138M 19.04M 149M |
---|---|---|---|---|---|
Net income 2023 | -379M -52.34M -409M | Net income 2024 * | -250M -34.53M -270M | EV / Sales 2023 | 3.76 x |
Net cash position 2023 | 4.44M 613K 4.79M | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | 1.06 x |
P/E ratio 2023 |
-1.03
x | P/E ratio 2024 * |
-0.55
x | Employees | 100 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 90% |
Latest transcript on CANbridge Pharmaceuticals Inc.
1 day | +4.48% | ||
1 week | +4.48% | ||
Current month | -18.60% | ||
1 month | +9.38% | ||
3 months | -19.54% | ||
6 months | -65.00% | ||
Current year | -64.65% |
Managers | Title | Age | Since |
---|---|---|---|
James Xue
CEO | Chief Executive Officer | 55 | 18-01-29 |
Glenn Hassan
DFI | Director of Finance/CFO | 46 | 19-04-01 |
Gerald Cox
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Hu
BRD | Director/Board Member | 61 | 22-07-04 |
James Geraghty
BRD | Director/Board Member | 69 | 18-07-17 |
Peng Kuan Chan
BRD | Director/Board Member | 60 | 21-06-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 0.35 | +4.48% | 37,000 |
24-05-22 | 0.335 | -2.90% | 152,000 |
24-05-21 | 0.345 | +2.99% | 15,000 |
24-05-20 | 0.335 | -5.63% | 95,000 |
24-05-17 | 0.355 | +7.58% | 182,000 |
Delayed Quote Hong Kong S.E., May 23, 2024 at 04:08 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-64.65% | 18.23M | |
+9.28% | 8.74B | |
-15.14% | 4.94B | |
+50.73% | 4.7B | |
+4.36% | 3.98B | |
-26.13% | 2.28B | |
+12.07% | 2.28B | |
+16.45% | 2.14B | |
-33.59% | 2.12B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 1228 Stock